MEDICINOVA, INC. Research and Development Arrangement, Contract to Perform for Others, Compensation Earned
MEDICINOVA, INC. (MNOV) reported Research and Development Arrangement, Contract to Perform for Others, Compensation Earned of $0 for the 3-month period ending 2015-06-30, per its 10-Q filed 2015-07-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned · last filed 2015-07-30
- MEDICINOVA, INC. research and development arrangement, contract to perform for others, compensation earned for the quarter ending 2015-06-30 was $0.00.
- MEDICINOVA, INC. research and development arrangement, contract to perform for others, compensation earned for the quarter ending 2015-03-31 was $0.00.
- MEDICINOVA, INC. research and development arrangement, contract to perform for others, compensation earned for the quarter ending 2014-12-31 was $0.00.
- MEDICINOVA, INC. research and development arrangement, contract to perform for others, compensation earned for the quarter ending 2014-09-30 was $0.00.
- MEDICINOVA, INC. research and development arrangement, contract to perform for others, compensation earned for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- MEDICINOVA, INC. research and development arrangement, contract to perform for others, compensation earned for fiscal 2013 was $3.00K, a 99.63% decline from fiscal 2012.
- MEDICINOVA, INC. research and development arrangement, contract to perform for others, compensation earned for fiscal 2012 was $800.00K.
| Period end | Research and Development Arrangement, Contract to Perform for Others, Compensation Earned | Research and Development Arrangement, Contract to Perform for Others, Compensation Earned 1 month | Research and Development Arrangement, Contract to Perform for Others, Compensation Earned 3 month | Research and Development Arrangement, Contract to Perform for Others, Compensation Earned 3 month as first filed | Research and Development Arrangement, Contract to Perform for Others, Compensation Earned 6 month | Research and Development Arrangement, Contract to Perform for Others, Compensation Earned 9 month | Research and Development Arrangement, Contract to Perform for Others, Compensation Earned 9 month as first filed | Research and Development Arrangement, Contract to Perform for Others, Compensation Earned 12 month |
|---|---|---|---|---|---|---|---|---|
| 2015-06-30 | $0.00 10-Q · filed 2015-07-30 | $0.00 10-Q · filed 2015-07-30 | $0.00 derived: sum of 3 quarters · filed 2015-07-30 | $0.00 derived: sum of 4 quarters · filed 2015-07-30 | ||||
| 2015-03-31 | $0.00 10-Q · filed 2015-05-11 | $0.00 derived: sum of 2 quarters · filed 2015-05-11 | $0.00 derived: sum of 3 quarters · filed 2015-05-11 | $0.00 derived: sum of 4 quarters · filed 2015-07-30 | ||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $0.00 derived: sum of 2 quarters · filed 2015-03-12 | $0.00 derived: sum of 3 quarters · filed 2015-07-30 | $0.00 10-K · filed 2015-03-12 | ||||
| 2014-09-30 | $0.00 10-Q · filed 2014-11-13 | $0.00 derived: sum of 2 quarters · filed 2015-07-30 | $0.00 10-Q · filed 2014-11-13 | -$257.00 derived: sum of 4 quarters · filed 2015-07-30 | ||||
| 2014-06-30 | $0.00 10-Q · filed 2015-07-30 | $0.00 10-Q · filed 2015-07-30 | -$257.00 derived: sum of 3 quarters · filed 2015-07-30 | -$257.00 derived: sum of 4 quarters · filed 2015-07-30 | ||||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-11 | -$257.00 derived: sum of 2 quarters · filed 2015-05-11 | -$257.00 derived: sum of 3 quarters · filed 2015-05-11 | -$257.00 derived: sum of 4 quarters · filed 2015-05-11 | ||||
| 2013-12-31 | -$257.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | -$257.00 derived: sum of 2 quarters · filed 2015-03-12 | -$257.00 derived: sum of 3 quarters · filed 2015-03-12 | $3.00K 10-K · filed 2015-03-12 | ||||
| 2013-09-30 | $0.00 10-Q · filed 2014-11-13 | $0.00 derived: sum of 2 quarters · filed 2014-11-13 | $3.26K 10-Q · filed 2014-11-13 | $3.00K 10-Q · filed 2013-11-07 | $3.26K derived: sum of 4 quarters · filed 2014-11-13 | |||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-13 | $3.26K 10-Q · filed 2014-08-13 | $3.26K derived: sum of 3 quarters · filed 2014-08-13 | $103.26K derived: sum of 4 quarters · filed 2014-08-13 | ||||
| 2013-03-31 | $3.26K 10-Q · filed 2014-05-08 | $3.00K 10-Q · filed 2013-05-08 | $3.26K derived: sum of 2 quarters · filed 2014-05-08 | $103.26K derived: sum of 3 quarters · filed 2014-05-08 | $603.26K derived: sum of 4 quarters · filed 2014-05-08 | |||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $100.00K derived: sum of 2 quarters · filed 2014-03-27 | $600.00K derived: sum of 3 quarters · filed 2014-03-27 | $800.00K 10-K · filed 2014-03-27 | ||||
| 2012-09-30 | $100.00K 10-Q · filed 2013-11-07 | $600.00K derived: sum of 2 quarters · filed 2013-11-07 | $800.00K 10-Q · filed 2013-11-07 | |||||
| 2012-06-30 | $500.00K 10-Q · filed 2013-08-08 | $700.00K 10-Q · filed 2013-08-08 | ||||||
| 2012-03-31 | $191.00K 10-Q · filed 2013-05-08 | |||||||
| 2011-10-31 | $2.50M 10-K · filed 2015-03-12 | $2.50M 10-Q · filed 2015-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |